Kymera Therapeutics, Inc. - COMMON STOCK (KYMR)

CUSIP: 501575104

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / COMMON STOCK
Shares outstanding
81,496,373
Total 13F shares
52,859,306
Share change
+1,319,884
Total reported value
$1,150,805,258
Put/Call ratio
22%
Price per share
$21.77
Number of holders
119
Value change
+$29,150,428
Number of buys
73
Number of sells
42

Security key

501575104

Report period

Q3 2022

Institutions

119

Top holders

10

Top shareholders of KYMR - Kymera Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
ATLAS VENTURE ASSOCIATES X, L.P.
3/4/5
10%+ Owner
class O/S missing
5,763,012
$173,161,222 11 Aug 2021
Atlas Venture Life Science Advisors, LLC
13F
Company
8.4%
6,875,698
$135,382,000 30 Jun 2022
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
6.4%
5,224,686
$102,874,000 30 Jun 2022
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
6.2%
5,034,940
$99,137,000 30 Jun 2022
13F
BVF INC/IL
13F
Company
5.1%
4,138,758
$81,492,000 30 Jun 2022
13F
STATE STREET CORP
13F
Company
4.3%
3,514,438
$69,199,000 30 Jun 2022
13F
BAKER BROS. ADVISORS LP
13F
Company
3.5%
2,879,825
$56,704,000 30 Jun 2022
13F
VANGUARD GROUP INC
13F
Company
3.5%
2,874,724
$56,604,000 30 Jun 2022
13F
BlackRock Finance, Inc.
13F
Company
3.5%
2,828,434
$55,691,000 30 Jun 2022
13F
Redmile Group, LLC
13F
Company
3.2%
2,607,130
$51,334,000 30 Jun 2022
13F
Avoro Capital Advisors LLC
13F
Company
1.5%
1,260,000
$24,809,000 30 Jun 2022
13F
Bank of New York Mellon Corp
13F
Company
1.3%
1,024,662
$20,175,000 30 Jun 2022
13F
Artal Group S.A.
13F
Company
1.2%
1,000,000
$19,690,000 30 Jun 2022
13F
Rock Springs Capital Management LP
13F
Company
0.95%
775,879
$15,277,000 30 Jun 2022
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.83%
675,847
$13,307,000 30 Jun 2022
13F
PICTET ASSET MANAGEMENT SA
13F
Company
0.79%
646,075
$12,721,000 30 Jun 2022
13F
Deer Management Co. LLC
13F
Company
0.76%
615,895
$12,127,000 30 Jun 2022
13F
JPMORGAN CHASE & CO
13F
Company
0.74%
603,378
$11,880,000 30 Jun 2022
13F
WASATCH ADVISORS LP
13F
Company
0.7%
570,644
$11,236,000 30 Jun 2022
13F
S.c.a. Candriam
13F
Individual
0.58%
469,843
$9,251,000 30 Jun 2022
13F
AJU IB Investment Co., Ltd.
13F
Company
0.56%
457,059
$8,999,000 30 Jun 2022
13F
FMR LLC
13F
Company
0.43%
346,784
$6,828,000 30 Jun 2022
13F
MORGAN STANLEY
13F
Company
0.41%
334,140
$6,580,000 30 Jun 2022
13F
NORTHERN TRUST CORP
13F
Company
0.41%
333,378
$6,564,000 30 Jun 2022
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.34%
277,264
$5,459,000 30 Jun 2022
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.31%
256,542
$5,052,000 30 Jun 2022
13F
NORGES BANK
13F
Company
0.29%
238,417
$4,694,431 30 Jun 2022
13F
BARCLAYS PLC
13F
Company
0.29%
233,137
$4,590,000 30 Jun 2022
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.28%
231,700
$4,562,000 30 Jun 2022
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
0.28%
226,859
$4,467,000 30 Jun 2022
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
0.24%
194,324
$3,826,240 30 Jun 2022
13F
CITIGROUP INC
13F
Company
0.23%
190,801
$3,757,000 30 Jun 2022
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.23%
187,281
$3,687,000 30 Jun 2022
13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC
13F
Company
0.21%
172,272
$3,392,000 30 Jun 2022
13F
Rafferty Asset Management, LLC
13F
Company
0.18%
150,339
$2,960,000 30 Jun 2022
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.18%
143,957
$2,835,000 30 Jun 2022
13F
Nuveen Asset Management, LLC
13F
Company
0.16%
126,784
$2,496,000 30 Jun 2022
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.15%
119,112
$2,346,000 30 Jun 2022
13F
UBS Group AG
13F
Company
0.14%
111,469
$2,194,000 30 Jun 2022
13F
Woodline Partners LP
13F
Company
0.12%
100,000
$1,969,000 30 Jun 2022
13F
GILDER GAGNON HOWE & CO LLC
13F
Company
0.12%
95,073
$1,872,000 30 Jun 2022
13F
Squarepoint Ops LLC
13F
Company
0.1%
79,328
$1,562,000 30 Jun 2022
13F
Swiss National Bank
13F
Company
0.1%
78,700
$1,550,000 30 Jun 2022
13F
TD ASSET MANAGEMENT INC
13F
Company
0.09%
76,676
$1,510,000 30 Jun 2022
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.08%
65,825
$1,326,103 30 Jun 2022
13F
BANK OF MONTREAL /CAN/
13F
Company
0.07%
59,370
$1,176,000 30 Jun 2022
13F
RHUMBLINE ADVISERS
13F
Company
0.07%
54,888
$1,081,000 30 Jun 2022
13F
Ensign Peak Advisors, Inc
13F
Company
0.06%
46,417
$914,000 30 Jun 2022
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.05%
44,491
$876,000 30 Jun 2022
13F
TUDOR INVESTMENT CORP ET AL
13F
Company
0.05%
41,312
$813,000 30 Jun 2022
13F

Institutional Holders of Kymera Therapeutics, Inc. - COMMON STOCK (KYMR) as of Q3 2022

As of 30 Sep 2022, Kymera Therapeutics, Inc. - COMMON STOCK (KYMR) was held by 119 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 52,859,306 shares. The largest 10 holders included Atlas Venture Life Science Advisors, LLC, BVF INC/IL, PRICE T ROWE ASSOCIATES INC /MD/, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., BAKER BROS. ADVISORS LP, Redmile Group, LLC, VANGUARD GROUP INC, STATE STREET CORP, and Avoro Capital Advisors LLC. This page lists 119 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders
99
Q3 2022 holders
119
Holder diff
20
Investor Q2 2022 Shares Q3 2022 Shares Share Diff Share Chg % Q2 2022 Value $ Q3 2022 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .